1 First step
|
(1) Blood sample volume >10 mL |
(2) Negative selection for CTC enrichment (RosetteSep®, etc.) or Ficoll-Paque density gradient centrifugation |
(3) Hypoxic conditions within 10 days (7 days is recommended) |
(4) Low attachment plate or gel formation |
(5) Growth factors (such as EGF, FGF, and B-27) and anti-apoptotic supplements (including Y-27632) with FCS |
2 Option
|
(1) Preservation of CD45(+) cells. |
(2) Normoxic conditions and attachment plates dependent on the cell type |
(3) Microfluidic device or nanotechnology-based method |
(4) Serum-free medium |
(5) Co-culture with normal leukocytes or fibroblasts |
(6) Culture medium changes under the microscopic ministering of cell clusters |
(7) Exclusion criteria |
(i) the use of chemotherapy and/or antibody-based therapy in the past 4 weeks |
(ii) the use of radiotherapy in the past 2 weeks |
3 Second step (after 7 to 14 days of the initial culture)
|
(1) Transfer to normoxic conditions |
(2) Standard culture medium |
4 Third step (after several weeks)
|
(1) No standard method |
(2) Select specific conditions depending on each cell |
(3) Careful management |
5 Critical steps
|
(1) Medium changes at 200 μL/min or less every 72 h [64] |
(2) In the case of a highly proliferative culture, an increased frequency of medium changes |
(3) To prevent the excessive stimulation of normal blood cells, the use of anti-apoptotic supplements for long periods is not recommended |